Award notice Supplies
Bévacizumab
Notice published in French. The AI analysis summarises it for you in your language.
- Public buyer
- Cliniques universitaires Saint Luc
Woluwe-Saint-Lambert - Place of performance
- 1200 Bruxelles, Brussels-Capital
- Planned end of contract
- 4 April 2029
likely re-tender around October 2028 - Bids received
- 4
- Form
- Framework agreement
Multi-year contract: the buyer places orders as needs arise. - Procedure
- Open procedure
Any company may submit a bid. - Publication
- 7 April 2025
- Notice language
- French
AI analysis: go for it or not?
Summary in English, criteria, documents to provide and a GO / NO GO verdict in one minute.
Unlimited analyses during the 14-day Pro trial, no card needed.
Description
Le marché concerne les fournitures de la spécialité pharmaceutique contenant le principe actif "Bévacizumab" pour injection en flacons "ready to use" de 100 mg et 400 mg
Awarded to
- Pfizer BCE/KBO 0401.994.823
CPV codes
European codes that classify what the contract is about. They are how we find the tenders for your trade.
33690000
Winning prices for comparable contracts
- A quarter below
- €444,216
- Median
- €606,904
- A quarter above
- €1,514,536
Amounts awarded (excl. VAT) over the last 3 years for 27 contracts in the same CPV group (3369…), excluding framework agreements. Half of the contracts fall between the two quartiles. TED source: mostly contracts above the EU thresholds, so amounts tend to be high.
Similar contracts already awarded
| Contract | Winner | Amount |
|---|---|---|
| Installation, mise en service, et maintenance d’une solution pré- et post-analytique automatisée et d’automates connectés pour des prestations de biologie clinique, ainsi que la fourniture des réactifs et des consommables associés Cliniques universitaires Saint Luc · 9 April 2026 |
Roche Diagnostics Belgium S.A. | €59,347,307 |
| Fourniture d'un automate permettant la réalisation de tests moléculaires rapides (PCR en temps réel) Cliniques universitaires Saint Luc · 16 December 2025 |
Aidian Belgium B.V. | €2,576,800 |
| Automatisation de l'auto-immunité Cliniques universitaires Saint Luc · 29 July 2024 |
Biognost BV | – |
| Luspatercept VITAZ vzw · 22 October 2026 |
Orifarm Belgium | €3,000,000 |
| Raamovereenkomst voor afname van dialyseconcentraten AZ Sint-Lucas vzw · 21 October 2026 |
HEMOTECH BELUX | €1,128,000 |
Source : TED – Office des publications de l'Union européenne © Union européenne, données retraitées. Reference 220636-2025.